Nevada: Market and regulatory data analysis of the cannabis sector

7th August 2024: US - Nevada: The Nevada Supreme Court has overruled a lower court decision and will allow cannabis to remain a Schedule I drug under state law. The plaintiffs claimed that cannabis could not remain a Schedule I drug after it was legalised via ballot initiative in 2016. The Supreme Court, however, based its decision on lack of standing by the plaintiffs in bringing the lawsuit and did not address the merits of the claims.
25th October 2023: US - Nevada: The Nevada Cannabis Compliance Board (CCB) approved amendments to regulations to modernise them after an executive order to do so earlier this year, press reports. Among the amendments is replacing the cannabis establishment licence number with a cannabis establishment ID number, which is required on cannabis product labelling. The CCB also approved six conditional cannabis consumption lounge licences.
22nd June 2023: US - Nevada: The Nevada Cannabis Compliance Board (CCB) has approved the first conditional licences for cannabis consumption lounges. It has also adopted new regulations broadening ventilation requirements, aimed at reducing barriers of entry for potential licensees.
20th June 2023: US - Nevada: Senate Bill 277 has been signed and enacted into law by governor Joe Lombardo. The bill increases the limits on possession, delivery and production for adults (21+) from 1 oz of cannabis to 2.5 oz, and from 0.125 oz to 0.25 oz for concentrated cannabis. It also removes the restriction on selling more than 1 oz of cannabis per transaction at medical dispensaries. And it establishes a dual licence for medical and recreational retailers and instructs the Cannabis Advisory Commission to conduct a study on the potential impact of state and federal rescheduling of cannabis.
15th June 2023: US - Nevada: Senate Bill 277 has been passed by the House and now heads to the governor’s desk. The bill proposes increasing limits on possession, delivery and production for adults (21+) from 1 oz of cannabis to 2.5 oz, and from an eighth of an oz to a quarter of an oz for concentrated cannabis. It also aims to remove the restriction on selling more than 1 oz of cannabis per transaction at medical dispensaries. Furthermore, it proposes the establishment of a dual licence for medical and recreational retailers and instructs the Cannabis Advisory Commission to conduct a study on the potential impact of state and federal rescheduling of cannabis.
15th June 2023: US - Nevada: Governor Joe Lombardo has signed Senate Bill 242, establishing the Psychedelic Medicines Working Group on the use of psilocybin and psilocin for medicinal, therapeutic and wellness purposes. The legislation, sponsored by Democratic senator Rochelle Nguyen, underwent revisions after initial introduction and focuses on initiating a conversation about psychedelics reform.
13th June 2023: US - New Jersey: The New Jersey Cannabis Regulatory Commission (CRC) has revoked Harmony Foundation’s cannabis cultivation and manufacturing licences due to unpaid licence fees. Across the country, state regulators and government bodies have been implementing significant measures and repercussions against cannabis companies that fail to pay vendors, taxes or business fees. California, Michigan, Nevada, New York and Oregon are some of the states that have been enforcing compliance by tracking miscreants, press reports.
1st June 2023: US - Nevada: Senate Bill 277 has been passed by the Senate and now heads to the House. The bill aims to ease adult-use cannabis regulations by increasing the authorised possession, delivery, and production limits for over-21s from 1 oz to 2.5 oz of cannabis and from an eighth of an ounce to a quarter of an ounce for concentrated cannabis. It would also remove the prohibition on selling more than 1 oz of cannabis per transaction at medical cannabis dispensaries. And it would direct the Cannabis Advisory Commission to conduct a study on the potential effects of state and federal rescheduling of cannabis.
26th May 2023: US - Nevada: The Nevada Legislature has passed a resolution urging Congress to legalise cannabis on a federal level. The Assembly Joint Resolution 8 (AJR8) highlights the medical uses of cannabis and the discrepancies between state and federal classifications. It emphasises the financial barriers faced by cannabis businesses due to federal prohibition and the need for improved access to banking services. Ultimately, the resolution urges Congress to remove cannabis from Schedule I of the Controlled Substances Act.
1st December 2022: US - Nevada: The Nevada Cannabis Compliance Board (CCB) has issued 20 prospective licences for cannabis consumption lounges that were determined via a lottery of applicants. Ten provisional licences were issued to social equity applicants (applicants who have been convicted of a cannabis offence, had a family member convicted of a cannabis offence, or who lived in an area impacted by a prohibitionist drug policy). Prospective licensees must still pass a suitability investigation by the CCB before their licences will be issued. Another 20 applicants were approved for consumption lounges that must be attached to a licensed operational cannabis dispensary.
17th October 2022: US - Nevada: The Nevada Cannabis Compliance Board (CCB) is now accepting applications for cannabis consumption lounges. The application process is open until 27th October.
15th September 2022: US - Nevada: A judge has ruled that the Nevada Board of Pharmacy may no longer list cannabis as a Schedule I drug, press reports. The American Civil Liberties Union (ACLU), which brought the lawsuit, claimed the Schedule I listing, despite voters passing an initiative in 2016 to legalise cannabis, created a loophole that allowed law enforcement to arrest people unjustly for cannabis offences.

LATEST ALERTS

Cannabis and cannabinoids in Nevada

US cannabis firms leave the business over industry ‘challenges and changes’

Cannabis legalisation set to come out on top no matter who wins US midterms

22nd Century integrates CBD company to grow its hemp/cannabis franchise faster

A regulatory analysis of cannabis consumption lounges in the US

Which US states allow the sale of intoxicating hemp-derived cannabinoids in dispensaries?

US medical cannabis products: a state-by-state regulatory report

US regulatory tracker: state regulation of delta-8 THC, October

US regulatory tracker: proposed state laws, October

US regulatory tracker: enacted regulation of CBD, October

Sign up to our newsletter

LATEST ALERTS

Cannabis and cannabinoids in Nevada

Sign up to our newsletter

Start your FREE trial